{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:45:08Z","timestamp":1794350708966,"version":"4.9.0"},"reference-count":131,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020582","name":"National Institute of Pharmaceutical Education and Research, Raebareli","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.ejmech.2022.114653","type":"journal-article","created":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T12:07:26Z","timestamp":1660133246000},"page":"114653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["New structural classes of antimalarials"],"prefix":"10.1016","volume":"242","author":[{"given":"Gajanan K.","family":"Rathod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna K.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samarpita","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahana","family":"Basak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9180-2812","authenticated-orcid":false,"given":"Rahul","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2022.114653_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111983","article-title":"Current progress in antimalarial pharmacotherapy and multi-target drug discovery","volume":"188","author":"Tibon","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib2","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1016\/j.bmc.2009.02.050","article-title":"Antimalarials from nature","volume":"17","author":"Kaur","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib3","series-title":"World Malaria Report 2021","year":"2021"},{"key":"10.1016\/j.ejmech.2022.114653_bib4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm.3073","article-title":"Malaria biology and disease pathogenesis: insights for new treatments","volume":"19","author":"Miller","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2022.114653_bib5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Clinical Trials Partnership. Efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial","volume":"386","author":"RTS","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2022.114653_bib6","doi-asserted-by":"crossref","first-page":"10526","DOI":"10.1021\/acs.jmedchem.9b00761","article-title":"The development process for discovery and clinical advancement of modern antimalarials","volume":"62","author":"Ashton","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1039\/C7MD00637C","article-title":"Recent updates in the discovery and development of novel antimalarial drug candidates","volume":"9","author":"Okombo","year":"2018","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2022.114653_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/med.20062","article-title":"Recent advances in antimalarial drug development","volume":"27","author":"Vangapandu","year":"2007","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2022.114653_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1472-8206.2009.00709.x","article-title":"Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development","volume":"23","author":"Na-Bangchang","year":"2009","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2022.114653_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0163-7258(00)00115-7","article-title":"Mode of action and mechanisms of resistance for antimalarial drugs","volume":"89","author":"Olliaro","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2022.114653_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nm.4381","article-title":"Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic","volume":"23","author":"Blasco","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2022.114653_bib12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1051\/parasite\/2018021","article-title":"Plasmodium falciparum resistance to artemisinin-based combination therapies: a sword of Damocles in the path toward malaria elimination","volume":"25","author":"Ouji","year":"2018","journal-title":"Parasite"},{"key":"10.1016\/j.ejmech.2022.114653_bib13","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/138955709787316074","article-title":"Drug resistance in Plasmodium: natural products in the fight against malaria","volume":"9","author":"Turschner","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002456","article-title":"malERA: an updated research agenda for insecticide and drug resistance in malaria elimination and eradication","volume":"14","author":"Rabinovich","year":"2017","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2022.114653_bib15","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ijpara.2010.04.001","article-title":"Transporters as mediators of drug resistance in Plasmodium falciparum","volume":"40","author":"Sanchez","year":"2010","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2022.114653_bib16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/9781118493816.ch14","article-title":"Antimalarial drug resistance","author":"Shah","year":"2016","journal-title":"Adv. Malaria Res."},{"key":"10.1016\/j.ejmech.2022.114653_bib17","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1126\/science.152.3727.1374","article-title":"Chloroquine: physiological basis of drug resistance in Plasmodium berghei","volume":"152","author":"Macomber","year":"1966","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.114653_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1286-4579(01)01524-6","article-title":"Mechanisms of resistance of Plasmodium falciparum to antimalarial drugs","volume":"4","author":"Hyde","year":"2002","journal-title":"Microb. Infect."},{"key":"10.1016\/j.ejmech.2022.114653_bib19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1126\/science.1074045","article-title":"Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations","volume":"298","author":"Sidhu","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.114653_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-13-152","article-title":"High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania","volume":"13","author":"Matondo","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2022.114653_bib21","first-page":"26","article-title":"Resistance to artemisinin combination therapies (ACTs): do not forget the partner drug","volume":"4","author":"Nsanzabana","year":"2019","journal-title":"Trav. Med. Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114653_bib22","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2022.114653_bib23","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrd1416","article-title":"Antimalarial drug discovery: efficacy models for compound screening","volume":"3","author":"Fidock","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114653_bib24","doi-asserted-by":"crossref","first-page":"11164","DOI":"10.1021\/cr500123g","article-title":"Recycling classical drugs for malaria","volume":"114","author":"Teixeira","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2022.114653_bib25","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ijpara.2008.03.004","article-title":"In vitro evaluations of antimalarial drugs and their relevance to clinical outcomes","volume":"38","author":"Ekland","year":"2008","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2022.114653_bib26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrd4573","article-title":"Malaria medicines: a glass half full?","volume":"14","author":"Wells","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114653_bib27","doi-asserted-by":"crossref","first-page":"18364","DOI":"10.1039\/C5RA19673F","article-title":"A structure guided drug-discovery approach towards identification of Plasmodium Inhibitors","volume":"6","author":"Aneja","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2022.114653_bib28","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd4683","article-title":"Hit and lead criteria in drug discovery for infectious diseases of the developing world","volume":"14","author":"Katsuno","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2022.114653_bib29","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/clpt.2009.51","article-title":"The global portfolio of new antimalarial medicines under development","volume":"85","author":"Olliaro","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2022.114653_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2022.114653_bib31","first-page":"1","article-title":"The past, present and future of anti-malarial medicines","volume":"18","author":"Edwin","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2022.114653_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111983","article-title":"Current progress in antimalarial pharmacotherapy and multi-target drug discovery","volume":"188","author":"Tibon","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib33","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.1021\/cr500543f","article-title":"Antimalarials in development in 2014","volume":"114","author":"Barnett","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2022.114653_bib34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1039\/C6NJ03181A","article-title":"Biologically active pyrazole derivatives","volume":"41","author":"Ansari","year":"2017","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ardp.201100078","article-title":"Synthesis and biological evaluation of some pyrazole derivatives as anti-malarial agents","volume":"345","author":"Bekhit","year":"2012","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ejmech.2022.114653_bib36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.ejmech.2009.10.023","article-title":"Synthesis and antimalarial evaluation of 1, 3, 5-trisubstituted pyrazolines","volume":"45","author":"Acharya","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2013.06.049","article-title":"Synthesis of novel analogs of 2-pyrazoline obtained from [(7-chloroquinolin-4-yl) amino] chalcones and hydrazine as potential antitumor and antimalarial agents","volume":"67","author":"Insuasty","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib38","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1016\/j.bmcl.2005.08.023","article-title":"Synthesis of 2-[3, 5-substituted pyrazol-1-yl]-4, 6-trisubstituted triazine derivatives as antimalarial agents","volume":"15","author":"Katiyar","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114653_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejmech.2014.07.084","article-title":"A comprehensive review on synthetic approach for antimalarial agents","volume":"85","author":"Kumar","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejmech.2018.11.067","article-title":"Synthesis, in silico experiments and biological evaluation of 1, 3, 4-trisubstituted pyrazole derivatives as antimalarial agents","volume":"163","author":"Bekhit","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ejmech.2018.11.044","article-title":"Hydroxyazole scaffold-based Plasmodium falciparum dihydroorotate dehydrogenase inhibitors: synthesis, biological evaluation and X-ray structural studies","volume":"163","author":"Pippione","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib42","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/00304949409458050","article-title":"Recent developments in tetrazole chemistry","volume":"26","author":"Wittenberger","year":"1994","journal-title":"A review, Org. Prep. Proced. Int."},{"key":"10.1016\/j.ejmech.2022.114653_bib43","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ejmech.2018.12.001","article-title":"Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents","volume":"163","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ejmech.2013.05.023","article-title":"Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivatives as potent antimalarial agents","volume":"66","author":"Pandey","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib45","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1016\/j.bmc.2013.06.067","article-title":"Tetrazole-based deoxyamodiaquines: synthesis, ADME\/PK profiling and pharmacological evaluation as potential antimalarial agents","volume":"21","author":"Tukulula","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib46","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1016\/j.ejmech.2010.04.011","article-title":"Quinolines and structurally related heterocycles as antimalarials","volume":"45","author":"Kaur","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7258(98)00012-6","article-title":"Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents","volume":"79","author":"Foley","year":"1998","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2022.114653_bib48","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ejmech.2018.12.001","article-title":"Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents","volume":"163","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib49","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1021\/ml300362a","article-title":"Synthesis and antiplasmodial and antimycobacterial evaluation of new nitroimidazole and nitroimidazooxazine derivatives","volume":"4","author":"Tukulula","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114653_bib50","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejmech.2012.08.047","article-title":"The design, synthesis, in silico ADME profiling, antiplasmodial and antimycobacterial evaluation of new arylamino quinoline derivatives","volume":"57","author":"Tukulula","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib51","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejmech.2019.01.047","article-title":"Triazole derivatives and their antiplasmodial and antimalarial activities","volume":"166","author":"Chu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib52","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1002\/cmdc.201100265","article-title":"Synthesis and antimalarial activities of a diverse set of triazole-containing furamidine analogues","volume":"6","author":"Berger","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.114653_bib53","first-page":"128","article-title":"Synthesis of novel sulfonamides as potential antibacterial, antifungal and antimalarial agents","volume":"54B","author":"Mistry","year":"2015","journal-title":"Indian J. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib54","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s00044-009-9206-8","article-title":"Synthesis and biological activity studies of furan derivatives","volume":"19","author":"Lo\u011fo\u011flu","year":"2010","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2022.114653_bib55","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00531499","article-title":"Biological activity of furan derivatives","volume":"29","author":"Lukevits","year":"1993","journal-title":"Chem. Heterocycl. Compd."},{"key":"10.1016\/j.ejmech.2022.114653_bib56","first-page":"231","article-title":"Search for new pharmacophore as antimalarial agent: synthesis and antimalarial activity of some 2 (3h)-furanones bearing quinoline moiety","volume":"68","author":"Alam","year":"2011","journal-title":"Acta Pol. Pharm. Drug Res."},{"key":"10.1016\/j.ejmech.2022.114653_bib57","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.ijpara.2004.10.003","article-title":"Cysteine proteases of malaria parasites","volume":"34","author":"Rosenthal","year":"2004","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.ejmech.2022.114653_bib58","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/cmdc.201100189","article-title":"Development of antitrypanosomal and antiplasmodial nonpeptidic cysteine protease inhibitors based on N-Protected-Guanidino-Furan and -pyrrole building blocks","volume":"6","author":"Langolf","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.114653_bib59","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.ejmech.2016.12.024","article-title":"Novel inhibitors of Plasmodium falciparum based on 2,5-disubstituted furans","volume":"126","author":"Krake","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib60","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1016\/j.bmcl.2011.05.131","article-title":"Synthesis and biological activities of 4-N-(anilinyl-n-[oxazolyl])-7-chloroquinolines (n= 3\u2032 or 4\u2032) against Plasmodium falciparum in in vitro models","volume":"21","author":"Gordey","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114653_bib61","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.bmcl.2010.11.081","article-title":"A new antimalarial bromotyrosine alkaloid from a marine sponge of the genus Pseudoceratina","volume":"21","author":"Xu","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114653_bib62","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bmc.2013.10.050","article-title":"Antiprotozoal activity of dicationic 3, 5-diphenylisoxazoles, their prodrugs and aza-analogues","volume":"22","author":"Patrick","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib63","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1021\/acs.jcim.5b00742","article-title":"Revealing the binding process of new 3-Alkylpyridine marine alkaloid analogue antimalarials and the heme group: an experimental and theoretical investigation","volume":"56","author":"Ribeiro-Viana","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2022.114653_bib64","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1016\/j.bmcl.2009.05.017","article-title":"Design, synthesis and structure\u2013activity relationships of (1H-pyridin-4-ylidene) amines as potential antimalarials","volume":"19","author":"Rodrigues","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114653_bib65","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2022.114653_bib66","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1021\/jm3001373","article-title":"3, 5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential","volume":"55","author":"Younis","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib67","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3109\/14756366.2011.575071","article-title":"Synthesis and biological screening of some pyridine derivatives as anti-malarial agents","volume":"27","author":"Bekhit","year":"2012","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib68","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1021\/ml300419r","article-title":"Antimalarial and structural studies of pyridine-containing inhibitors of 1-deoxyxylulose-5-phosphate reductoisomerase","volume":"4","author":"Xue","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114653_bib69","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/med.21634","article-title":"Morpholine as a privileged structure: a review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules","volume":"40","author":"Kourounakis","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2022.114653_bib70","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1007\/s00044-015-1455-0","article-title":"Synthesis of novel mono-and bis-Schiff bases of morpholine derivatives and the investigation of their antimalarial and antiproliferative activities","volume":"24","author":"Jarrahpour","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2022.114653_bib71","first-page":"34","article-title":"Synthesis of new \u03b2-lactams bearing the biologically important morpholine ring and POM analyses of their antimicrobial and antimalarial activities, Iran","volume":"18","author":"Jarrahpour","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejmech.2022.114653_bib72","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.ejmech.2011.02.054","article-title":"Expeditious synthesis and biological evaluation of novel 2, N6-disubstituted 1, 2-dihydro-1, 3, 5-triazine-4, 6-diamines as potential antimalarials","volume":"46","author":"Gravestock","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib73","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1021\/acs.jmedchem.1c00044","article-title":"Discovery of potent and fast-acting antimalarial bis-1, 2, 4-triazines","volume":"64","author":"Priebbenow","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib74","first-page":"232","article-title":"Benzimidazole derivatives: spectrum of pharmacological activity and toxicological properties, Pharma","volume":"33","author":"Spasov","year":"1999","journal-title":"Chemother. J."},{"key":"10.1016\/j.ejmech.2022.114653_bib75","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.bmc.2011.01.050","article-title":"Synthesis and biological evaluation of benzimidazole-5-carbohydrazide derivatives as antimalarial, cytotoxic and antitubercular agents","volume":"19","author":"Camacho","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib76","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1021\/jm200227r","article-title":"Antimalarial pyrido [1, 2-a] benzimidazoles","volume":"54","author":"Ndakala","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib77","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.inoche.2013.06.019","article-title":"Organometallic benzimidazoles: synthesis, characterization and antimalarial activity","volume":"35","author":"Toro","year":"2013","journal-title":"Inorg. Chem. Commun."},{"key":"10.1016\/j.ejmech.2022.114653_bib78","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejmech.2005.09.001","article-title":"Synthesis and antiprotozoal activity of some 2-(trifluoromethyl)-1H-benzimidazole bioisosteres","volume":"41","author":"Navarrete-V\u00e1zquez","year":"2006","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113518","article-title":"Discovery and development of 2-aminobenzimidazoles as potent antimalarials","volume":"221","author":"Devine","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib80","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1021\/acs.jmedchem.1c00354","article-title":"Antimalarial benzimidazole derivatives incorporating phenolic Mannich base side chains inhibit microtubule and hemozoin formation: structure\u2013activity relationship and in vivo oral efficacy studies","volume":"64","author":"Dziwornu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib81","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.3390\/molecules22071099","article-title":"Synthesis and evaluation of N-(3-trifluoroacetyl-indol-7-yl) acetamides for potential in vitro antiplasmodial properties","volume":"22","author":"Mphahlele","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114653_bib82","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejmech.2016.02.056","article-title":"Indolyl-3-ethanone-\u03b1-thioethers: a promising new class of non-toxic antimalarial agents","volume":"114","author":"Svogie","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib83","doi-asserted-by":"crossref","first-page":"525","DOI":"10.4155\/fmc-2018-0246","article-title":"Indole-3-glyoxyl tyrosine: synthesis and antimalarial activity against Plasmodium falciparum","volume":"11","author":"Vasconcelos","year":"2019","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib84","doi-asserted-by":"crossref","first-page":"9300","DOI":"10.1021\/acs.jmedchem.0c00451","article-title":"Development of potent Pf CLK3 inhibitors based on TCMDC-135051 as a new class of antimalarials","volume":"63","author":"Mahindra","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib85","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejmech.2017.11.064","article-title":"Quinoxaline: an insight into the recent pharmacological advances","volume":"143","author":"Tariq","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib86","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.ejmech.2007.11.024","article-title":"Synthesis and structure\u2013activity relationship of 3-phenylquinoxaline 1, 4-di-N-oxide derivatives as antimalarial agents","volume":"43","author":"Vicente","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib87","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/14756366.2016.1268608","article-title":"Design, synthesis and antimalarial activity of novel bis {N-[(pyrrolo [1, 2-a] quinoxalin-4-yl) benzyl]-3-aminopropyl} amine derivatives","volume":"32","author":"Guillon","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113687","article-title":"Further investigation of harmicines as novel antiplasmodial agents: synthesis, structure-activity relationship and insight into the mechanism of action","volume":"224","author":"Marinovi\u0107","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib89","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1021\/acsmedchemlett.1c00663","article-title":"Malaria box-inspired discovery of N-Aminoalkyl-\u03b2-carboline-3-carboxamides, a novel orally active class of antimalarials","volume":"13","author":"Mathew","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114653_bib90","doi-asserted-by":"crossref","first-page":"591","DOI":"10.5530\/ijper.50.4.11","article-title":"Synthesis and antimalarial activity evaluation of some Mannich bases of tetraoxane-phenol conjugate","volume":"50","author":"Jinky","year":"2016","journal-title":"Ind. J. Pharm. Edu. Res."},{"key":"10.1016\/j.ejmech.2022.114653_bib91","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1747-0285.2012.01345.x","article-title":"Synthesis and antimalarial activity of dihydroperoxides and tetraoxanes conjugated with bis (benzyl) acetone derivatives","volume":"79","author":"Franco","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2022.114653_bib92","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1021\/acs.jmedchem.5b01485","article-title":"Antimalarial chemotherapy: natural product inspired development of preclinical and clinical candidates with diverse mechanisms of action: miniperspective","volume":"59","author":"Fernandez-Alvaro","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib93","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bmcl.2017.12.060","article-title":"Semisynthesis, cytotoxicity, antimalarial evaluation and structure-activity relationship of two series of triterpene derivatives","volume":"28","author":"Cargnin","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2022.114653_bib94","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jep.2011.02.026","article-title":"Renaissance remedies: antiplasmodial protostane triterpenoids from Alisma plantago-aquatica L.(Alismataceae)","volume":"135","author":"Adams","year":"2011","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2022.114653_bib95","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1021\/np100325q","article-title":"Antiplasmodial triterpenoids from the fruits of neem, Azadirachta indica","volume":"73","author":"Chianese","year":"2010","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2022.114653_bib96","first-page":"315","article-title":"In vitro antimalarial activity of cryptolepine, an indoquinoline","volume":"85","author":"Noamesi","year":"1991","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2022.114653_bib97","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ptr.2650090510","article-title":"In vitro and in vivo antimalarial activity of cryptolepine, a plant-derived indoloquinoline","volume":"9","author":"Kirby","year":"1995","journal-title":"Phytother Res."},{"key":"10.1016\/j.ejmech.2022.114653_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-017-2142-z","article-title":"In vitro anti-malarial interaction and gametocytocidal activity of cryptolepine","volume":"16","author":"Forkuo","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.ejmech.2022.114653_bib99","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1021\/jm101383f","article-title":"Incorporation of basic side chains into cryptolepine scaffold: structure\u2212 antimalarial activity relationships and mechanistic studies","volume":"54","author":"Lavrado","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112215","article-title":"Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: a key review","volume":"193","author":"Qin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib101","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmech.2006.09.019","article-title":"A review of anti-infective and anti-inflammatory chalcones","volume":"42","author":"Nowakowska","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib102","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/jm300588j","article-title":"Synthesis and insight into the structure\u2013activity relationships of chalcones as antimalarial agents","volume":"56","author":"Tadigoppula","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib103","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1747-0285.2012.01383.x","article-title":"Antimalarial activity of newly synthesized chalcone derivatives in vitro","volume":"80","author":"Yadav","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2022.114653_bib104","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejmech.2014.07.087","article-title":"Synthesis, biological evaluation and molecular docking of novel chalcone\u2013coumarin hybrids as anticancer and antimalarial agents","volume":"85","author":"Pingaew","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib105","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.3390\/molecules26041008","article-title":"Nopol-based quinoline derivatives as antiplasmodial agents","volume":"26","author":"Nyamwihura","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2022.114653_bib106","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/10412905.2006.12067134","article-title":"The biological activities of 20 nature identical essential oil constituents","volume":"18","author":"Van Zyl","year":"2006","journal-title":"J. Essent. Oil Res."},{"key":"10.1016\/j.ejmech.2022.114653_bib107","doi-asserted-by":"crossref","first-page":"7650","DOI":"10.1128\/AAC.01948-15","article-title":"In vitro activities of primaquine-schizonticide combinations on asexual blood stages and gametocytes of Plasmodium falciparum","volume":"59","author":"Cabrera","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2022.114653_bib108","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/md14010016","article-title":"Marine isonitriles and their related compounds","volume":"14","author":"Emsermann","year":"2016","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2022.114653_bib109","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1039\/b302359c","article-title":"Marine isocyanides and related natural products\u2013structure, biosynthesis and ecology","volume":"21","author":"Garson","year":"2004","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2022.114653_bib110","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3390\/md7020130","article-title":"Taglialatela-Scafati O. Marine antimalarials","volume":"7","author":"Fattorusso","year":"2009","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2022.114653_bib111","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1021\/np50090a014","article-title":"Antimalarial activity of sesquiterpenes from the marine sponge Acanthella klethra","volume":"55","author":"Angerhofer","year":"1992","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2022.114653_bib112","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0040-4020(76)80065-8","article-title":"Axisonitrile-3, axisothiocyanate-3 and axamide-3. Sesquiterpenes with a novel spiro[4,5]decane skeleton from the sponge Axinella cannabina","volume":"32","author":"Di Blasio","year":"1976","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2022.114653_bib113","doi-asserted-by":"crossref","first-page":"13467","DOI":"10.1016\/S0040-4020(98)00818-7","article-title":"Antimalarial activity of kalihinol A and new relative diterpenoids from the Okinawan sponge","volume":"54","author":"Miyaoka","year":"1998","journal-title":"Acanthella sp, Tetrahedron"},{"key":"10.1016\/j.ejmech.2022.114653_bib114","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1021\/ja00328a073","article-title":"A highly functionalized diisocyano diterpenoid antibiotic from a sponge","volume":"106","author":"Chang","year":"1984","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114653_bib115","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.1021\/jacs.6b03899","article-title":"Synthesis of (+)-7,20-diisocyanoadociane and liver-stage antiplasmodial activity of the isocyanoterpene class","volume":"138","author":"Lu","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2022.114653_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115678","article-title":"Natural product-inspired aryl isonitriles as a new class of antimalarial compounds against drug-resistant parasites","volume":"28","author":"Kyei-Baffour","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib117","doi-asserted-by":"crossref","first-page":"6709","DOI":"10.1021\/acs.orglett.0c01665","article-title":"A family of antiplasmodial macrolides isolated from the fungus strasseria geniculata CF-247251","volume":"22","author":"Annang","year":"2020","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2022.114653_bib118","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1021\/acs.orglett.1c04340","article-title":"Total syntheses of strasseriolide A and B, antimalarial macrolide natural products","volume":"24","author":"Salituro","year":"2022","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2022.114653_bib119","doi-asserted-by":"crossref","first-page":"7849","DOI":"10.1021\/acs.joc.5b01264","article-title":"Bastimolide A, a potent antimalarial polyhydroxy macrolide from the marine cyanobacterium Okeania hirsuta","volume":"80","author":"Shao","year":"2015","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/acs.jnatprod.7b00917","article-title":"Bastimolide B, an antimalarial 24-membered marine macrolide possessing a tert-butyl group","volume":"81","author":"Shao","year":"2018","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2022.114653_bib121","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1021\/jm0603724","article-title":"Discovery of a new boron-containing antifungal agent, 5-fluoro-1, 3-dihydro-1-hydroxy-2, 1-benzoxaborole (AN2690), for the potential treatment of onychomycosis","volume":"49","author":"Baker","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2022.114653_bib122","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.1142189","article-title":"An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site","volume":"316","author":"Rock","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2022.114653_bib123","doi-asserted-by":"crossref","first-page":"5963","DOI":"10.1016\/j.bmcl.2006.08.130","article-title":"Identification of a novel boron-containing antibacterial agent (AN0128) with anti-inflammatory activity, for the potential treatment of cutaneous diseases","volume":"16","author":"Baker","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114653_bib124","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1016\/j.bmcl.2010.02.010","article-title":"Design and synthesis of boron-containing PDE4 inhibitors using soft-drug strategy for potential dermatologic anti-inflammatory application","volume":"20","author":"Zhang","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114653_bib125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/ml100013s","article-title":"Discovery of novel benzoxaborole-based potent antitrypanosomal agents","volume":"1","author":"Ding","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114653_bib126","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1016\/j.tetlet.2011.05.088","article-title":"An efficient synthesis for a new class antimalarial agent, 7-(2-carboxyethyl)-1, 3-dihydro-1-hydroxy-2, 1-benzoxaborole","volume":"52","author":"Zhang","year":"2011","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2022.114653_bib127","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.bmcl.2011.12.096","article-title":"Benzoxaborole antimalarial agents. Part 2: discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1 benzoxaboroles","volume":"22","author":"Zhang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2022.114653_bib128","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/infdis\/jis418","article-title":"Identification of a new chemical class of antimalarials","volume":"206","author":"Brunner","year":"2012","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ejmech.2022.114653_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002138","article-title":"Characterization of novel antimalarial compound ACT-451840: preclinical assessment of activity and dose\u2013efficacy modeling","volume":"13","author":"Le Bihan","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.ejmech.2022.114653_bib130","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/cmdc.201600298","article-title":"Discovery and characterization of ACT\u2010451840: an antimalarial drug with a novel mechanism of action","volume":"11","author":"Boss","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2022.114653_bib131","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1021\/acs.jmedchem.0c01744","article-title":"3-Hydroxy-propanamidines, a new class of orally active antimalarials targeting Plasmodium falciparum","volume":"64","author":"Knaab","year":"2021","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422005554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422005554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:41:45Z","timestamp":1759329705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422005554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":131,"alternative-id":["S0223523422005554"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114653","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New structural classes of antimalarials","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114653","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114653"}}